BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38817646)

  • 1. Management of cerebral amyloid angiopathy and atrial fibrillation: We are still far from precision medicine.
    Fusco L; Palamà Z; Scarà A; Borrelli A; Robles AG; De Masi De Luca G; Romano S; Sciarra L
    World J Cardiol; 2024 May; 16(5):231-239. PubMed ID: 38817646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort.
    Schrag M; Mac Grory B; Nackenoff A; Eaton J; Mistry E; Kirshner H; Yaghi S; Ellis CR
    Transl Stroke Res; 2021 Apr; 12(2):259-265. PubMed ID: 32770310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation.
    Cannistraro RJ; Meschia JF
    Curr Cardiol Rep; 2018 Sep; 20(11):106. PubMed ID: 30209626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies.
    Merella P; Casu G; Chessa P; Atzori E; Bandino S; Deiana G
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral amyloid angiopathy and atrial fibrillation: anticoagulant dilemma].
    Boutitie L; Verny M; Alamowitch S; Zerah L
    Geriatr Psychol Neuropsychiatr Vieil; 2023 Mar; 21(1):81-89. PubMed ID: 37115683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Amyloid Angiopathy and Atrial Fibrillation: An up to Date Case Report.
    Battistin U; AlQassim N; Hallak Y; Mohammed M; Hasan A; Oluwole OJ
    Neurohospitalist; 2022 Apr; 12(2):391-394. PubMed ID: 35419135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy.
    Narita K; Amiya E; Komuro I
    Cureus; 2020 Aug; 12(8):e10143. PubMed ID: 32884877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention in an octogenarian with atrial fibrillation, cerebral amyloid angiopathy and intracerebral hemorrhage.
    Stöllberger C; Finsterer J; Schneider B
    Clin Case Rep; 2023 Jun; 11(6):e7630. PubMed ID: 37384229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebral amyloid angiopathy, comorbid atrial fibrillation].
    Novosadova OA; Semenova TN; Grigoryeva VN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):46-52. PubMed ID: 33908232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracerebral hemorrhage under platelet inhibition and oral anticoagulation in patients with cerebral amyloid angiopathy].
    Haußmann R; Homeyer P; Haußmann M; Brandt M; Donix M; Puetz V; Linn J
    Nervenarzt; 2022 Jun; 93(6):599-604. PubMed ID: 34652485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
    Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
    J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Mortality Rates Among Patients With Non-Traumatic Intracerebral Hemorrhage and Atrial Fibrillation on Antithrombotic Therapy Are Independent of the Presence of Cerebral Amyloid Angiopathy: Insights From a Population-Based Study.
    Ponamgi SP; Ward R; DeSimone CV; English S; Hodge DO; Slusser JP; Graff-Radford J; Rabinstein AA; Asirvatham SJ; Holmes D
    J Am Heart Assoc; 2020 Aug; 9(15):e016893. PubMed ID: 32715895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time in therapeutic range of anticoagulation among patients with atrial fibrillation and cerebral amyloid angiopathy.
    Ward RC; Graff-Radford J; Ponamgi S; English S; Meskill A; Challa AB; Hodge DO; Slusser JP; Rabinstein AA; Asirvatham SJ; Holmes D; DeSimone CV
    Proc (Bayl Univ Med Cent); 2022; 35(2):162-167. PubMed ID: 35261442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
    J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.
    Freeman JV; Hutton DW; Barnes GD; Zhu RP; Owens DK; Garber AM; Go AS; Hlatky MA; Heidenreich PA; Wang PJ; Al-Ahmad A; Turakhia MP
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27307517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
    Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP
    Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of HAS-BLED and CHA
    Ward R; Ponamgi S; DeSimone CV; English S; Hodge DO; Slusser JP; Graff-Radford J; Rabinstein AA; Asirvatham SJ; Holmes D
    Mayo Clin Proc; 2020 Oct; 95(10):2090-2098. PubMed ID: 32829908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.